Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of Histoplasma Antigen in Urine

Histoplasmosis is a major cause of mortality in people living with HIV (PLHIV). Rapid methods to diagnose Histoplasma capsulatum disease could dramatically decrease the time to initiate treatment, resulting in reduced mortality. The aim of this study was to validate a MiraVista® Diagnostics (MVD) Histoplasma urine antigen lateral flow assay (MVD LFA) for the detection of H. capsulatum antigen (Ag) in urine and compare this LFA against the MVista® Histoplasma Ag quantitative enzyme immunoassays (MVD EIA). We assessed the MVD LFA using a standardized reference panel of urine specimens from Colombia. We tested 100 urine specimens, 26 from PLHIV diagnosed with histoplasmosis, 42 from PLHIV with other infectious diseases, and 32 from non-HIV infected persons without histoplasmosis. Sensitivity and specificity of the MVD LFA was 96%, compared with 96% sensitivity and 77% specificity of the MVD EIA. Concordance analysis between MVD LFA and the MVD EIA displayed an 84% agreement, and a Kappa of 0.656. The MVD LFA evaluated in this study has several advantages, including a turnaround time for results of approximately 40 min, no need for complex laboratory infrastructure or highly trained laboratory personnel, use of urine specimens, and ease of performing.

[1]  Deving Arias Ramos,et al.  Closing gaps in histoplasmosis: clinical characteristics and factors associated with probable/histoplasmosis in HIV/AIDS hospitalized patients, a retrospective cross-sectional study in two tertiary centers in Pereira, Colombia , 2021, AIDS Research and Therapy.

[2]  T. Chiller,et al.  Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV , 2021, Mycoses.

[3]  J. P. Telles,et al.  Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease. , 2021, Medical mycology.

[4]  G. Reyes-Terán,et al.  Diagnostic accuracy of antigen detection in urine and molecular assays testing in different clinical samples for the diagnosis of progressive disseminated histoplasmosis in patients living with HIV/AIDS: A prospective multicenter study in Mexico , 2021, PLoS neglected tropical diseases.

[5]  S. Lockhart,et al.  Endemic and Other Dimorphic Mycoses in The Americas , 2021, Journal of fungi.

[6]  N. Govender,et al.  Cross-reactivity of a Histoplasma capsulatum antigen enzyme immunoassay in urine specimens from persons with emergomycosis in South Africa. , 2020, Medical mycology.

[7]  D. Denning,et al.  Comparative performance of the laboratory assays used by a diagnostic laboratory hub for opportunistic infections in people living with HIV. , 2020, AIDS.

[8]  P. Garner,et al.  Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV , 2020 .

[9]  T. Chiller,et al.  Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS , 2020, Mycoses.

[10]  J. Perfect,et al.  Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Diego H. Cáceres,et al.  Diagnosis of Progressive Disseminated Histoplasmosis in Advanced HIV: A Meta-Analysis of Assay Analytical Performance , 2019, Journal of Fungi.

[12]  Audrey Valdes,et al.  Histoplasmosis and Tuberculosis Co-Occurrence in People with Advanced HIV , 2019, Journal of fungi.

[13]  Mathieu Nacher,et al.  The Fight against HIV-Associated Disseminated Histoplasmosis in the Americas: Unfolding the Different Stories of Four Centers , 2019, Journal of fungi.

[14]  A. Chakrabarti,et al.  Can urinary histoplasma antigen test improve the diagnosis of histoplasmosis in a tuberculosis endemic region? , 2019, Mycoses.

[15]  A. Schwarzbold,et al.  Histoplasmosis, An Underdiagnosed Disease Affecting People Living With HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection , 2019, Open forum infectious diseases.

[16]  Mathieu Nacher,et al.  Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. , 2018, The Lancet. Infectious diseases.

[17]  T. Chiller,et al.  Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries , 2018, Journal of Clinical Microbiology.

[18]  T. Chiller,et al.  The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia , 2018, Medical mycology case reports.

[19]  L. Goldani,et al.  Disseminated histoplasmosis and AIDS: a prospective and multicentre study to evaluate the performance of different diagnostic tests , 2017, Mycoses.

[20]  M. Brandt,et al.  Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital. , 2016, The American journal of tropical medicine and hygiene.

[21]  Chen Zhang,et al.  Evaluation of two new enzyme immunoassay reagents for diagnosis of histoplasmosis in a cohort of clinically characterized patients. , 2015, Medical mycology.

[22]  G. Sarosi,et al.  Histoplasmosis Infections Worldwide: Thinking Outside of the Ohio River Valley , 2015, Current Tropical Medicine Reports.

[23]  M. Brandt,et al.  Validation of an Enzyme-Linked Immunosorbent Assay That Detects Histoplasma capsulatum Antigenuria in Colombian Patients with AIDS for Diagnosis and Follow-Up during Therapy , 2014, Clinical and Vaccine Immunology.

[24]  M. Hanf,et al.  Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study. , 2014, The American journal of tropical medicine and hygiene.

[25]  Beatriz L. Gómez,et al.  Histoplasmosis y sida: factores de riesgo clínicos y de laboratorio asociados al pronóstico de la enfermedad , 2012 .

[26]  R. de Aguiar Cordeiro,et al.  In Vitro Effect of Sulfamethoxazole-Trimethoprim against Histoplasma capsulatum var. capsulatum , 2010, Antimicrobial Agents and Chemotherapy.

[27]  T. Davis,et al.  Improved Detection of Histoplasma Antigenemia following Dissociation of Immune Complexes , 2009, Clinical and Vaccine Immunology.

[28]  L. Wheat,et al.  Detection of Histoplasma Antigen by a Quantitative Enzyme Immunoassay , 2007, Clinical and Vaccine Immunology.

[29]  L. Wheat,et al.  Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. , 2002, Diagnostic microbiology and infectious disease.

[30]  P. Connolly,et al.  Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  L. Wheat,et al.  Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. , 1989, The American journal of medicine.